U. S. Securities and Exchange Commission
                            Washington, D. C. 20549

                                 FORM 10-QSB

[X]    	QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
        EXCHANGE ACT OF 1934

        For the quarterly period ended September 30, 2005

[ ]    	TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
        EXCHANGE ACT OF 1934

        For the transition period from _____ to _____

                       Commission File No. 33-14987-A

                CARE RECRUITMENT SOLUTIONS INTERNATIONAL, INC.
                ----------------------------------------------
                (Name of Small Business Issuer in its Charter)


              Florida                                  65-0023471
   ------------------------------------------------------------------------
   (State or Other Jurisdiction of              (I.R.S. Employer I.D. No.)
    incorporation or organization)

                 826 Broadway, 9th Floor, New York, NY 10003
                 -------------------------------------------
                   (Address of Principal Executive Offices)

                  Issuer's Telephone Number: (212) 505-0282

Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Sections 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that
the Registrant was required to file such reports),  and (2) has been subject
to such filing requirements for the past 90 days.    Yes [X]     No  [ ]

Indicate by check mark whether the registrant is a shell company (as
defined in Rule 12b-2 of the Exchange Act).  Yes [X]    No [ ]

APPLICABLE ONLY TO CORPORATE ISSUERS:  Indicate the number of shares
outstanding of each of the Registrant's classes of common stock, as of the
latest practicable date:
                         March 29, 2006
                         Common Voting Stock: 21,457,817 shares

Transitional Small Business Disclosure Format (check one):    Yes [ ]  No [X]

<PAGE>
                               CRSI Group, Inc.
                        (A Development Stage Company)
                                Balance Sheet
                             September 30, 2005
                                 (Unaudited)

ASSETS

Fixed Assets, net of accumulated depreciation
  of $9,918                                     $    46,040
                                                   --------
Total Assets                                    $    46,040
                                                   ========

LIABILITIES AND STOCKHOLDERS' DEFICIENCY

Current Liabilities
 Cash Overdraft                                 $       297
 Accounts Payable and Accrued Expenses              132,119
 Accrued Expenses - Related Party                    47,236
 Accrued Compensation - Related Party               260,820
 Loan Payable - Related Party                       222,774
 Accrued Interest Payable - Related Party             2,691
                                                  ---------
Total Current Liabilities                           665,937
                                                  ---------
Commitments and Contingencies

Stockholders' Deficiency
 Preferred stock, no par value; 5,000,000
  shares authorized, none issued and
  outstanding                                             -
 Common stock, no par value; 200,000,000
  shares authorized, 21,357,817 shares
  issued and outstanding                            611,789
 Deficit accumulated during the development
  stage                                          (1,231,686)
                                                  ---------
Total Stockholders' Deficiency                     (619,897)
                                                  ---------

Total Liabilities and Stockholders' Deficiency  $    46,040
                                                  =========

See accompanying notes to condensed consolidated financial statements

                                    -2-
<PAGE>



                                                                 For The
                               For The         For The        Period From
                                Three           Nine        October 18, 2004
                            Months Ended    Months Ended     (Inception) to
                            September 30,   September 30,     September 30,
                               30, 2005       30, 2005            2005
                           ---------------------------------------------------
REVENUES                    $        -      $        -         $        -

COST OF REVENUES                     -               -                  -
                             ---------       ---------          ---------
GROSS PROFIT                         -               -                  -
                             ---------       ---------          ---------
OPERATING EXPENSES
 Executive salaries             85,417         235,417            285,820
 Consulting fees               225,765         318,897            355,088
 Depreciation                    2,798           7,916              9,918
 General and administrative    339,494         476,620            578,169
                             ---------       ---------          ---------
Total Operating Expenses       653,474       1,038,850          1,228,995
                             ---------       ---------          ---------
LOSS FROM OPERATIONS          (653,474)     (1,038,850)        (1,228,995)

OTHER INCOME (EXPENSE)
 Interest expense               (1,430)         (2,360)            (2,691)
                             ---------       ---------          ---------
Total Other Income (Expense)    (1,430)         (2,360)            (2,691)
                             ---------       ---------          ---------
LOSS BEFORE PROVISION FOR
 INCOME TAXES                 (654,904)     (1,041,210)        (1,231,686)

Provision for Income Taxes           -               -                  -
                             ---------       ---------          ---------
NET LOSS                    $ (654,904)    $(1,041,210)       $(1,231,686)
                             =========       =========          =========
NET LOSS PER SHARE -
 BASIC AND DILUTED          $    (0.03)    $     (0.07)       $     (0.09)
                             =========       =========          =========
WEIGHTED AVERAGE NUMBER
 OF COMMON SHARES
 OUTSTANDING - BASIC AND
 DILUTED                    21,357,817      15,487,118         14,262,487
                            ==========      ==========         ==========

                                    -3-

See accompanying notes to condensed consolidated financial statements

<PAGE>

                       CRSI GROUP, INC. AND SUBSIDIARIES
                         (A DEVELOPMENT STAGE COMPANY)
                  CONDENSED CONSOLIDATED STATEMENT OF CHANGES
                           IN STOCKHOLDERS' EQUITY
    FOR THE PERIOD FROM OCTOBER 18, 2004 (INCEPTION) TO SEPTEMBER 30, 2005
                                  (UNAUDITED)

                                                          Accumulated
                                                          Deficit During
                   Preferred Stock     Common Stock       Development
                   Shares   Amount   Shares     Amount    Stage          Total
                   ------------------------------------------------------------
Balance,
 October 18,2004
 (inception)            -   $   -           - $      -     $      -    $      -

Common stock issued
 to founders for
 costs and equipment
 ($0.001 per share)     -       -   8,900,000   89,000            -      89,000

Stock issued for
 services ($0.05 per
 share)                 -       -     100,000    5,000            -       5,000

Stock issued for cash
 ($0.05 per share)      -       -   1,000,000   50,000            -      50,000

Net loss for the
 period from October
 18, 2004 (inception)
 to December 31, 2004   -       -           -        -     (190,476)   (190,476)
                     ----------------------------------------------------------
Balance,
 December 31, 2004      -       -  10,000,000  144,000     (190,476)    (46,476)

Stock issued for
 services ($0.05 per
 share)                 -       -     970,000   48,500            -      48,500

Stock issued to
 officer under
 employment
 agreement ($0.05
 per share)             -       -     539,877   26,994            -      26,994

Stock issued for cash
 ($0.05 per share)      -       -   7,300,000  365,000            -     365,000

Stock issued in
 connection with
 stockholder loan
 repayment ($0.05
 per share)             -       -     545,912   27,296            -      27,296

Shares issued in
 reverse merger         -       -   2,002,028        -            -           -

Net loss for the
 nine months ended
 September 30, 2005     -       -           -        -   (1,041,210) (1,041,210)
                   ------------------------------------------------------------
BALANCE,
 SEPTEMBER 30, 2005     -   $   -  21,357,817 $611,789  $(1,231,686) $ (619,897)
                   ============================================================



See accompanying notes to condensed consolidated financial statements

                                    -4-
<PAGE>


                                CRSI Group, inc.
                         (A Development Stage Company)
                            Statements of Cash Flows
                For the Nine Months Ended September 30, 2005
    for the Period from October 18, 2004 (Inception) to September 30, 2005
                                 (Unaudited)

                                   Nine Months Ended       October 18, 2004
                                   September 30, 2005       (Inception) to
                                                         September 30, 2005
                                   ------------------    --------------------
Cash Flows From Operating
 Activities:
 Net Loss                             $(1,041,210)           $(1,231,686)
  Adjustments to reconcile net
   loss to net cash used in
   operations
   Stock issue for services                75,494                 80,494
   Stock issued for start up costs              -                 40,950
   Depreciation                             7,916                  9,918
  Changes in operating assets and
   liabilities:
   Increase in accounts payable
    and accrued expenses                  132,121                132,121
   Decrease in accrued expenses
    - related party                             -                 51,984
   Increase in accrued compensation
    - related party                       260,820                260,820
   Increase in accrued interest
    payable - related party                 2,691                  2,691
                                       ----------             ----------
 Net Cash Used In Operating
  Activities                             (562,168)              (652,708)

Cash Flows From Investing Activities:
 Purchase of equipment                     (5,728)                (7,908)
                                       ----------             ----------
 Net Cash Used In Investing Activities     (5,728)                (7,908)
                                       ----------             ----------

Cash Flows From Financing Activities:
 Increase in cash overdraft                   297                    297
 Proceeds from issuance of common
  stock                                   365,000                415,000
 Proceeds from loan payable
  - related party                         171,322                253,360
 Repayment of loan payable
  - related party                          (8,041)                (8,041)
                                       ----------             ----------
 Net Cash Provided by Financing
  Activities                              528,578                660,616
                                       ----------             ----------
Net Increase (Decrease) in Cash           (39,318)                     -

Cash at Beginning of Period                39,318                      -
                                       ----------             ----------
Cash at End of Period                 $         -            $         -
                                       ==========             ==========

Supplemental disclosure of cash flow
 information:

 Cash paid for interest               $         -            $         -
                                       ==========             ==========

 Cash paid for taxes                  $         -            $         -
                                       ==========             ==========


Supplemental disclosure of non-cash investing and financing activities:

 Common stock issued to founders for
  costs and equipment ($0.001)        $         -            $    48,050
                                       ==========             ==========
 Stock issued in connection with
  shareholder loan repayment
  ($0.05 per share)                   $    27,296            $    27,296
                                       ==========             ==========

See accompanying notes to condensed consolidated financial statements

                                   -5-
<PAGE>
                      CRSI GROUP, INC. AND SUBSIDIARIES
                        (A DEVELOPMENT STAGE COMPANY)
             NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                          AS OF SEPTEMBER 30, 2005
                                (UNAUDITED)

NOTE 1	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION

     (A) Basis of Presentation

     The accompanying unaudited financial statements have been prepared in
accordance with generally accepted accounting principles and the rules and
regulations of the Securities and Exchange Commission for the interim
financial information.  Accordingly, they do not include all the information
and footnotes necessary for a comprehensive presentation of financial
position and results of operations.

     It is management's opinion, however, that all adjustments (consisting of
normal recurring adjustments) have been made which are necessary for a fair
financial statements presentation.  The results for the interim period are
not necessarily indicative of the results to be expected for the year.

     (B) Organization

     Abcor Products, Inc. (the "Company"), a development stage company, was
organized under the laws of the State of Florida on April 9, 1987 as HWS
Noviembre Corporation.  On May 19, 1989, the Company filed an amendment
to its articles of incorporation changing its name to Abcor Products, Inc.

     Care Recruitment Solutions International, Inc. ("CRSI"), was organized
under the laws of the State of Florida on October 18, 2004.  CRSI is a
development stage enterprise and intends to primarily provide international
recruiting, placement and staffing of nurses to hospitals and other health
care agencies.

     World Nursing Corps, Inc. ("WNC") is a development stage company
organized under the laws of the State of Florida on June 22, 2005 as a
wholly owned subsidiary of CRSI.  WNC was established to function as a
resource and support organization for nurses placed by CRSI.  WNC had
no operating activities, assets or liabilities as of September 30, 2005.

     On June 30, 2005, Abcor consummated an agreement with CRSI pursuant to
which CRSI exchanged all of its then issued and outstanding shares of
common stock for 17,995,912 (approximately 90%) of the common stock
shares of Abcor.  This "reverse" merger transaction is deemed to be a
recapitalization by CRSI.  CRSI is considered the accounting acquirer
and Abcor is considered the acquiree for financial reporting purposes.
Accordingly, the balance sheet contains the net assets of the accounting
acquirer and acquiree at historical cost and the statement of operations
includes the operations of the acquirer for the periods presented and the
operations of the acquiree from the date of the merger.

                                    -6-
<PAGE>
                      CRSI GROUP, INC. AND SUBSIDIARIES
                        (A DEVELOPMENT STAGE COMPANY)
             NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                          AS OF SEPTEMBER 30, 2005
                                (UNAUDITED)

     Activities during the development stage include developing a business
plan, obtaining financing and effecting a merger or acquisition.

     On August 22, 2005 the Company changed its name from Abcor Products,
Inc. to CRSI Group, Inc.

     Hereinafter, CRSI Group, inc. and its wholly owned subsidiaries, CRSI
and WNC may be referred to individually or in the aggregate as the "Company".

     (C) Use of Estimates

     In preparing financial statements in conformity with generally accepted
accounting principles, management is required to make estimates and
assumptions that affect the reported amounts of assets and liabilities
and the disclosure of contingent assets and liabilities at the date of
the financial statements and revenues and expenses during the reported
period.  Actual results could differ from those estimates.

     (D) Cash and Cash Equivalents

     The Company considers all highly liquid temporary cash investments with
an original maturity of three months or less to be cash equivalents.  The
Company did not have any cash or cash equivalents as of the balance sheet
dates presented in the financial statements.

     (E) Fixed Assets

     Furniture and equipment are stated at cost.  Depreciation is computed
using the straight-line method over five years which is the estimated
useful lives of the assets.  Maintenance and repairs are charged to
operations as incurred.

     (F) Income Taxes

     The Company accounts for income taxes under the Statement of Financial
Accounting Standards No. 109, "Accounting for Income Taxes" ("Statement
109").  Under Statement 109, deferred tax assets and liabilities are
recognized for the future tax consequences attributable to differences
between the financial statement carrying amounts of existing assets and
liabilities and their respective tax bases.  Deferred tax assets and
liabilities are measured using enacted tax rates expected to apply to
taxable income in the years in which those temporary differences are
expected to be recovered or settled.  Under Statement 109, the effect
on deferred tax assets and liabilities of a change in tax rates is
recognized in income in the period that includes the enactment date.

                                    -7-
<PAGE>
                      CRSI GROUP, INC. AND SUBSIDIARIES
                        (A DEVELOPMENT STAGE COMPANY)
             NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                          AS OF SEPTEMBER 30, 2005
                                (UNAUDITED)

     As of September 30, 2005, the Company had a $1,203,530 net operating
loss carry forward ("NOL"), of which $188,720 and $1,014,810, respectively,
expire on December 31, 2024 and 2025. A deferred tax asset of $391,807
comprised of $354,011 for federal income taxes and $37,796 for state income
taxes has been reserved by a valuation allowance to account for the potential
benefit of the NOL.

     (G) Principles of Consolidation

     The consolidated financial statements include the accounts of CRSI
Group, Inc. and its wholly owned subsidiaries, Care Recruitment
Solutions International, Inc., and World Nursing Corps, Inc.  All
significant intercompany accounts and transactions have been
eliminated.

     (H) Loss Per Share

     Basic and diluted net loss per common share is computed based upon the
weighted average common shares outstanding as defined by Financial
Accounting Standards No. 128, "Earnings Per Share."  As of September
30, 2005, there were 150,000 common share equivalents outstanding the
effect of which was anti-dilutive and not included in the calculation
of diluted net loss per common share.

     (I) Segment Information

     The Company operates in one segment and therefore segment information
is not presented.

     (J) Stock-Based Compensation

     The Company applies Accounting Principles Board ("APB") Opinion No. 25,
Accounting for Stock Issued to Employees, and Related Interpretations,
in accounting for stock warrants issued to employees.  Under APB No.
25, employee compensation cost is recognized when estimated fair value
of the underlying stock on date of grant exceeds exercise price of the
stock option.  For stock options and warrants issued to non-employees,
the Company applies Statements of Financial Accounting Standards ("SFAS")
No. 123, Accounting for Stock-Based Compensation, which requires the
recognition of compensation cost based upon the fair value of stock
warrants at the grant date using the Black-Scholes option pricing model.

                                    -8-
<PAGE>
                      CRSI GROUP, INC. AND SUBSIDIARIES
                        (A DEVELOPMENT STAGE COMPANY)
             NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                          AS OF SEPTEMBER 30, 2005
                                (UNAUDITED)

     (K) Recent Accounting Pronouncements

     Statement of Financial Accounting Standards ("SFAS") No. 154, "Accounting
Changes and Error Corrections - a replacement of APB Opinion No. 20 and FASB
Statement No. 3"; SFAS No. 151, "Inventory Costs - an amendment of ARB No.
43, Chapter 4"; SFAS No. 152, "Accounting for Real Estate Time-Sharing
Transactions - an amendment of FASB Statements No. 66 and 67"; SFAS No.
153, "Exchanges of Non-monetary Assets - an amendment of APB Opinion No.
29"; and SFAS No. 123 (revised 2004), "Share-Based Payment", were issued
after the Company's May 31, 2004 year-end and do not have applicability
to the Company's operations nor any impact on the Company's financial
statements.

NOTE 2  LOANS FROM STOCKHOLDER

     The Company's founder advanced funds to the Company throughout the
period from the Company's inception to September 30, 2005.  These loans
are unsecured, due on demand, and bear interest at 3% per annum.  As of
September 30, 2005, the Company owes the shareholder $222,774 of principal
and related accrued interest of $2,691.

NOTE 3	REVERSE MERGER

     On June 30, 2005, Abcor consummated a "reverse" merger with CRSI.
Immediately prior to the merger, Abcor had 2,002,028 shares of common
stock issued and outstanding (net of 20,000,000 shares canceled pursuant
to the merger).  CRSI exchanged 100% of its 17,995,912 issued and
outstanding common shares for common shares of Abcor on a 1 for 1 basis.
Immediately after the merger, Abcor had 19,997,940 shares of common stock
issued and outstanding.

     Simultaneous with the merger, the sole officer and director of Abcor
resigned and the management of CRSI assumed such positions; therefore,
effecting a change of control.  As a result, the transaction was recorded
as a "reverse merger" whereby CRSI was considered to be the accounting
acquirer although CRSI became a wholly owned subsidiary of Abcor.
Accordingly, the financial statements include the operating results of CRSI
for the periods presented and its balance sheet based on historical cost
accounting.  The financial statements will include the results of operations
of Abcor from the date of the merger.

     Subsequently the Board of Directors approved a change in fiscal year
from May 31 to December 31.  The Board of Directors also approved a
name change for the accounting acquiree from Abcor Products, Inc. to
CRSI Group, Inc., and an amendment to the articles of incorporation
changing the capital structure thereof as explained in Note 5.

                                    -9-
<PAGE>
                      CRSI GROUP, INC. AND SUBSIDIARIES
                        (A DEVELOPMENT STAGE COMPANY)
             NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                          AS OF SEPTEMBER 30, 2005
                                (UNAUDITED)

NOTE 4	RELATED PARTY TRANSACTIONS

     The Company has received working capital advances from its majority
stockholder of $222,774 from inception (See Note 2).

     During October 2004, the Company issued 8,900,000 shares of common stock
to reimburse him for an aggregate of $89,000 of start-up costs incurred and
office furniture and equipment.

     During October 2004, the Company entered into an employment agreement
with its majority stockholder and founder (See Note 6(A)).

     During October 2004, the Company entered into a one year office lease
agreement with an entity affiliated with the Company's majority stockholder
(See Note 6(B)).

     Additionally, the Company accrued $47,236 for various working capital
advances provided by a related party to the Company's President.  These
advances were non-interest bearing, unsecured and due on demand.

NOTE 5	STOCKHOLDERS' EQUITY

     The Board of Directors approved an amendment to the articles of
incorporation changing the capital structure as follows:

     A. Eliminate the 50,000,000 Class A common shares, none of which were
        issued or outstanding.

     B. Increase the authorized "ordinary" common shares from 150,000,000
        to 200,000,000.

     C. Eliminate the $1,000 par value, 12% redeemable and convertible
        preferred stock.

     D. Authorize the issuance of up to 5,000,000 shares of preferred stock
        the features, preferences and rights of which will be determined by
        the Board of Directors prior to issuance.

     The amendment was filed with the Florida Secretary of State after the
approval by the Company's stockholders became effective during the week
of August 22, 2005.

     Common stock issuances from October 18, 2004 (inception) to September
30, 2005 were as follows:
                                   -10-
<PAGE>
                      CRSI GROUP, INC. AND SUBSIDIARIES
                        (A DEVELOPMENT STAGE COMPANY)
             NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                          AS OF SEPTEMBER 30, 2005
                                (UNAUDITED)

     i.    On October 18, 2004 (date of inception), the Company issued its
           founder 8,900,000 shares of common stock to reimburse him for an
           aggregate of $89,000 of start-up costs incurred and office
           furniture and equipment purchased by the founder prior to the
           Company's incorporation.  The stock was valued at the historical
           cost of the start-up costs incurred and the office furniture and
           equipment purchased.
     ii.   On October 27, 2004, the Company issued 100,000 shares of common
           stock for consulting services pursuant to a consultant agreement
           related to the Company's entrance into the foreign trained nurse
           recruitment business.  The services were recorded in the statement
           of operations for $5,000 based on a recent cash offering price of
           the common stock ($0.05 per share).  The consulting agreement was
           scheduled to expire upon the rendering of the aforementioned
           services.  The Company deemed that as of December 31, 2004, the
           consultant earned the 100,000 issued shares for services rendered.

     iii.  On November 5, 2004, the Company issued 1,000,000 shares of common
           stock for cash of $50,000 ($0.05 per share).

     iv.   On April 25, 2005, the Company issued 150,000 shares of common
           stock for consulting services rendered without a formal agreement.
           The services were accrued as a liability on the March 31, 2005
           balance sheet and recorded in the statement of operations in the
           first quarter for $7,500 based on a recent cash offering price of
           the common stock ($0.05 per share).

     v.    On April 25, 2005 the Company issued 545,912 common shares to its
           majority shareholder as a partial payment of the outstanding
           shareholder loan balance.  The recorded payment amount of $27,295
           was determined by using the cash price of the common stock ($0.05
           per share) offered in a concurrent private placement memorandum.

     vi.   On April 27, 2005, the Company entered into an agreement with an
           unrelated party (hereinafter referred to as "CRS") to acquire 100%
           of the common stock of CRS in exchange for 17,995,912 common shares
           of the Company.  The consummation of the transaction is contingent
           upon the following conditions:

           a. The Company has been brought into full compliance with its
              reporting obligations under the Securities Exchange Act of 1934
              and (2) the Company has filed and mailed to its shareholders a
              statement complying with the requirements of SEC Rule 14f-1.

                                    -11-
<PAGE>
                      CRSI GROUP, INC. AND SUBSIDIARIES
                        (A DEVELOPMENT STAGE COMPANY)
             NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                          AS OF SEPTEMBER 30, 2005
                                (UNAUDITED)

           b. The "closing" of this agreement shall occur ten days after each
              of the two conditions referred to above have been satisfied.
              In the event the closing does not occur within 60 days after
              the date of the agreement, the agreement will terminate and
              have no further force or effect.

     vii.  On May 9, 2005, the Company issued 7,300,000 common shares at
           $0.05 per share pursuant to a private placement memorandum and
           raised $365,000.

     viii. On June 30, 2005 the Company issued 539,877 shares of common
           stock to an executive pursuant to an employment agreement.  The
           shares issued were contingent on the success of the private
           placement memorandum and the consummation of the "reverse" merger.
           The statement of operations includes $26,994 of consulting fees
           determined by use of the recent cash offering price of the common
           stock ($0.05).

     ix.   On June 30, 2005 the Company issued 120,000 shares of common stock
           for consulting services rendered.  The statement of operations
           includes $6,000 of consulting fees determined by use of the recent
           cash offering price of the common stock ($0.05).

     x.    On June 30, 2005, the Company issued 700,000 shares of common
           stock for consulting services rendered pursuant to the "reverse"
           merger.  The statement of operations includes $35,000 of consulting
           fees determined by use of the recent cash offering price of the
           common stock ($0.05).

     xi.   On June 30, 2005, the Company exchanged 2,002,028 shares of common
           stock for all the outstanding shares of Abcor.

     Stock Options

     The Company follows the provisions of APB 25, however, fair value
accounting and the related provisions of SFAS 123 for all share based
payment awards are presented in accordance with the provisions of SFAS
No. 123 as they pertain to the presentation of the pro forma effect if
the Company had used SFAS No. 123.  No compensation expense was recognized
during the period ended September 30, 2005 since the Company follows the
provisions of APB No. 25.

     The fair value of each option granted is estimated on the date of grant
using the Black-Scholes option pricing model.  The following is a summary of
all stock options granted to employees:

                                   -12-
<PAGE>
                      CRSI GROUP, INC. AND SUBSIDIARIES
                        (A DEVELOPMENT STAGE COMPANY)
             NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                          AS OF SEPTEMBER 30, 2005
                                (UNAUDITED)

     On July 1, 2005, the Company issued options to purchase 150,000 shares
of common stock having an exercise price of $0.55 per share to a
director for past services rendered.  These shares vested immediately
upon issuance.

     The weighted average assumptions used by management were as follows:


            Dividend yield               0%
            Expected volatility        140%
            Risk free interest rate   4.75%
            Expected life of option   3 years

     Employee stock option activity for the period ended September 30, 2005
is summarized as follows:


                                         Number of         Weighted Average
                                          Options           Exercise Price
                                   --------------------------------------------
Outstanding at December 31, 2004                -                $   -
Granted                                   150,000                 0.55
Exercised                                       -                    -
Cancelled                                       -                    -
                                         --------                 ----
Outstanding at September 30, 2005         150,000                $0.55
                                         ========                 ====


     The following table summarizes the Company's employee stock options
outstanding at September 30, 2005:

                                     Options Outstanding

                                                 Weighted      Weighted
                      Range of                   Average       Average
                      Exercise     Number        Remaining     Exercise
                      Price        Outstanding   Life          Price
                      --------------------------------------------------
                       $ 0.55       150,000       2.75 Years   $ 0.55
                        =====       =======       ==========    =====

                                   -13-
<PAGE>
                      CRSI GROUP, INC. AND SUBSIDIARIES
                        (A DEVELOPMENT STAGE COMPANY)
             NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                          AS OF SEPTEMBER 30, 2005
                                (UNAUDITED)

     All outstanding employee stock options are exercisable September 30, 2005.

     The exercise prices of all options granted by the Company equal the
market price at the dates of the grant.  No compensation expense has been
recognized.  Had compensation cost for the stock option plan been determined
based on the fair value of the options at the grant dates consistent with the
method of "SFAS 123, "Accounting for Stock Based Compensation", the Company's
net loss and loss per share would have been changed to the pro forma amounts
indicated below for the period ended September 30, 2005.


                                              September 30, 2005
                                              ------------------

            Net loss as reported               $  (1,041,210)
            Add:
             Total stock based compensation
             expense determined under fair
             value based method, net of
             related tax effect                         (537)
                                                   ---------
            Pro forma net loss                 $  (1,041,747)
                                                   =========
            Basic and diluted loss per share
             As reported                               (0.07)
             Pro forma                                 (0.07)

     The above pro forma disclosures may not be representative of the
effects on reported net earnings for future years as the Company may
continue to grant options to employees.

NOTE 6	COMMITMENTS

     (A) Employment Agreements

     The Company hired its founder as Chief Executive Officer (CEO) and
president pursuant to the terms of an employment agreement effective
October 19, 2004.  The term of the agreement is for five years with
annual renewal options thereafter.  The annual base salary is $250,000
with annual increases of 25% and an annual bonus equal to 8% of EBITDA.
 The CEO has the option of receiving the bonus in cash, common stock at
a 50% discount, or a combination of both.  As of September 30, 2005,
the aggregate amount of accrued executive salary payable to the CEO
totaled $237,903.
                                    -14-
<PAGE>
                      CRSI GROUP, INC. AND SUBSIDIARIES
                        (A DEVELOPMENT STAGE COMPANY)
             NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                          AS OF SEPTEMBER 30, 2005
                                (UNAUDITED)

     The Company hired a "Senior Vice-President, International Operations"
(Executive) pursuant to an employment agreement.  The effective date of
the agreement was to commence upon the raising of $250,000 of investment
capital by the Company, which was achieved on May 9, 2005.  The agreement
term is for the period from the effective date to December 31, 2008 and,
thereafter, shall be automatically extended annually for one year terms
unless the Company terminates the agreement upon six months prior notice.
The Company shall pay to the Executive an annual base salary of $175,000,
with annual increases of 12%.  The executive shall be entitled to an annual
bonus to be received in cash, common stock at a 50% discount, or a
combination of both at the executive's option.  The formula for the bonus
has not been determined.  The Company has also agreed to pay the executive
(1) an amount of the Company's common shares equal to 3% of the then issued
and outstanding shares of common stock on latter of the effective date or the
"reverse" merger consummation date and (2) a one-time amount of common stock
of the Company equal to 1.99% of the then issued and outstanding shares of
common stock at such time that the Company has achieved aggregate,
consolidated year-to-date revenues of at least $6.6 million.  The executive
was issued 539,877 common shares on June 30, 2005 upon consummation of the
"reverse" merger (See Note 5).  As of September 30, 2005, the aggregate
amount of accrued executive salary payable to the Executive was $22,917.

     The agreement with the Senior Vice President, International Operations
also stipulates that the executive will be given the opportunity to
participate in any executive employee stock option programs and shall
be entitled to purchase stock options at a price equal to the closing
bid price of the common shares on the date of the grant and shall be
exercisable for a period of ten years.  The agreement also provides
that the Executive will be paid a "business development fee" if the
Executive identifies a health care organization with which the Company
places a professional or if the Executive identifies a health care
professional that the Company places into a paying position.  The fee
will equal 11/2% of all revenues earned by the Company in the first three
years after such a placement and 11/2% of all payments made to the
Company by such a professional for services in the first three years
after the placement.

     The Company hired a Managing Director of CRSI Europe pursuant to an
employment agreement.  The effective date of the agreement was April
10, 2005.  The agreement term is for a period from the effective date
to December 31, 2008.

     (B) Lease - Office Premises

                      CRSI GROUP, INC. AND SUBSIDIARIES
                        (A DEVELOPMENT STAGE COMPANY)
             NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                          AS OF SEPTEMBER 30, 2005
                                (UNAUDITED)

     The Company executed a lease effective October 18, 2004 with an entity
affiliated with the Company's founder, for use of its office premises.
The lease term is for one year with one year annual renewal options
thereafter.  Monthly base rent is $500.  The nine months ended September
30, 2005 statement of operations includes in general and administrative
expenses $4,500 of rent expense pursuant to the lease term.  As of September
30, 2005, the aggregate amount of accrued rent which is included in the
balance sheet as a liability in the category of accrued expenses totaled
$4,750.
                                    -15-
<PAGE>

NOTE 7	PLACEMENT AGREEMENTS

     In April 2005 the Company entered into a five year "placement"
agreement with a national health care provider to provide a minimum
annual staffing of 150 nurses.  The agreement provides that the Company
will receive a $12,500 placement fee per nurse plus a $5,000 per nurse
training and immigration cost subsidy.  The agreement may be terminated
by either party with or without cause upon ninety days written notice.
At September 30, 2005, the agreement was still in effect although no
transactions under its terms have been consummated.

     In May 2005 the Company entered into a one-year agreement with a
placement agency to place approximately 220 nurses at the Company's
clients.  The Company is responsible to provide a loan to each
applicant to fund their visa application, training and relocation
expense and pay a fee of $1,000 upon acceptance and approval for
employment at a Company client, $500 upon signing of an employment
agreement and $500 upon the first date the nurse reports for work.  The
agreement is cancelable upon 90 days mutual consent by both parties.
As of September 30, 2005, the agreement has not been cancelled.

NOTE 8	GOING CONCERN

     The Company is in the development stage with no operations, has a
cumulative negative cash flow from operations of $652,708, has had
recurring losses since inception and has an accumulated deficit of
$1,231,686.  Accordingly, there is substantial doubt about the
Company's ability to continue as a going concern.  The ability of the
Company to continue as a going concern is dependent on the Company's
ability to raise additional capital and implement its business plan.
The financial statements do not include any adjustments that might be
necessary if the Company is unable to continue as a going concern.

                                   -16-
<PAGE>
                      CRSI GROUP, INC. AND SUBSIDIARIES
                        (A DEVELOPMENT STAGE COMPANY)
             NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                          AS OF SEPTEMBER 30, 2005
                                (UNAUDITED)

     As more fully discussed in Note 9, subsequent to the Company's year
end, the Company entered into an agreement for the exchange of common
stock with an unrelated party. Management believes that the successful
consummation of said agreement can provide the Company with the
opportunity to continue as a going concern.

     The Company is in the development stage.

NOTE 9	SUBSEQUENT EVENTS

     During October 2005 the Company received a loan of $60,000 from a
company related to the founder of CRSI Group.  The loan bears interest
at prime plus 2% and is payable in three monthly installments.  As of
March 28, 2006 the loan is in default, and the Company has obtained a
waiver of the default through May 2006.

     On January 31, 2006 the Company obtained an additional $20,000 in the
form of a Revolver Loan Agreement and Promissory Note from a related
party.  Interest will accrue at a rate of Prime plus 2% per annum.  The
principal amount is due in three equal monthly installments terminating
April 30, 2006.

     On February 28, 2006 the Company's Chairman released the Company from
all accrued compensation and debts that the Company owed to him.  The
Chairman also assumed personal liability for the Company's obligations
to the other two officers of the Company.  Those officers then released
the Company from all accrued compensation and other debts.

     On February 28, 2006 CRSI Group entered into a Share Exchange Agreement
with the equity-holders in three limited liability companies organized
in the Republic of Kazakhstan:  Scientific Industrial Firm Dank, LLC,
Central Geophysical Expedition LLC, and A-Fidan, LLC. (the "Caspian
Companies").  The Caspian Companies are engaged in oil production and
in certain  aspects of the oil services industry.  The Share Exchange
Agreement contemplates that CRSI Group will acquire 95% of the equity
in the Caspian Companies in exchange for 56,000,000 shares of common
stock issued by CRSI Group.  The closing of the acquisition will occur
after conditions specified in the Share Exchange Agreement have been
satisfied, primarily completion of satisfactory due diligence
investigations by both parties and the completion of the audits of the
financial statements of the Caspian Companies.

     In a separate agreement, fourteen shareholders of CRSI Group have
agreed that upon the closing of the acquisition of the Caspian
Companies, they will surrender a sufficient number of CRSI Group shares
to reduce the number outstanding prior to the share exchange to
6,000,000.  Accordingly, the 56,000,000 shares to be issued to the
equity-holders in the Caspian Companies will represent 90.3% of the
outstanding shares of CRSI Group.
                                   -17-
<PAGE>

ITEM 2.  PLAN OF OPERATION

        CRSI Group, Inc. is a holding company with two subsidiaries:  Care
Recruitment Solutions International, Inc. ("CRSI") and World Nursing Corps,
Inc. ("WNC").

        CRSI is an international nurse and medical personnel staffing and
recruiting company focused on the sourcing and placement of foreign-trained
Nurses, health caregivers and other medical personnel.  CRSI's business
plan contemplates that CRSI will recruit experienced Nurses and other
medical staff from selected foreign countries ("Source Countries"), provide
them further training in the UK, then deliver them for employment primarily
within the nursing profession in a variety of countries such as the UK, the
USA and other locations ("Target Countries").  CRSI nurses will be located
by CRSI for 1 to 3 year contracts or per-diem engagements throughout Target
Countries and other selected locations.  While CRSI is training nurses to
qualify as a nurse in a Target Country, CRSI will utilize the services of
these nurses immediately through its nursing and care staffing agencies and
clients, thus generating immediate revenues for CRSI.  CRSI's international
headquarters are located in New York City, and its European headquarters
and operations center are located in the UK.

        CRSI was organized in October 2004.  In April 2005 it entered into
its first placement contract.  The contract is with a health care provider
that employs medical personnel throughout the United States.  The contract
provides for a minimum annual placement of 150 nurses throughout its five
year term.  The health care provider is required to pay total fees of
$17,500 per nurse.  The contract may be terminated by either party on 90
days notice.   CRSI expects to initiate placements under the contract when
sufficient funds are available to finance its operations.

        CRSI has also acquired the rights to place 220 immigrant nurses with
employers.  The nurses are under contract to a placement agency in the US,
which has given CRSI the exclusive right to obtain approval of the nurses'
entry into the US from the immigration authorities and then to place the
nurses in employment with health care providers in the US.

	During CRSI's first year of operations its founder, Jeremy Feakins,
contributed $89,000 to CRSI and made additional loans to enable CRSI to
initiate its operations.  The net balance of the loan account at September
30, 2005 was $222,774.  CRSI also obtained $415,000 by selling common stock
to five private investors.  The funds were used primarily to pay the
expenses incurred as Mr. Feakins organized the network of institutional
relationships that are the foundation for CRSI's business plan.  Included
in the expenses recorded on Abcor's statement of operations since inception
is $285,820 in salary to Mr. Feakins and CRSI's Executive Vice President,
Ytzik Aranov.  All of the compensation payable to Mr. Feakins and half of
the compensation payable to Mr. Aranov has been accrued and is included in
"Accrued Compensation - Related Party" on CRSI's balance sheet at September
30, 2005.
                                   -18-
<PAGE>
	At September 30, 2005 CRSI had no cash remaining on hand.  It had
$665,937 in current liabilities, producing a working capital deficit of
($665,937).  Because of the lack of funds, CRSI has ceased its efforts to
expand its business and focused on raising capital.  In its report on
CRSI's financial statements for the year ended December 31, 2004, the
Company's auditor stated that there was substantial doubt as to its ability
to continue as a going concern.  In order to continue to implement its
business plan, CRSI Group will have to obtain additional capital.  For that
reason, management does not have enough cash to continue operations for
twelve months and has been actively soliciting additional equity
investment.  It has not, however, received financing commitments from
anyone at this time.

	On February 28, 2006 CRSI Group entered into a Share Exchange
Agreement with the equity-holders in three limited liability companies
organized in the Republic of Kazakhstan:  Scientific Industrial Firm Dank,
LLC, Central Geophysical Expedition LLC, and A-Fidan, LLC. (the "Caspian
Companies").  The Caspian Companies are engaged in oil production and in
certain  aspects of the oil services industry.  The Share Exchange Agreement
contemplates that CRSI Group will acquire 95% of the equity in the Caspian
Companies in exchange for 56,000,000 shares of common stock issued by CRSI
Group.  The closing of the acquisition will occur after conditions specified
in the Share Exchange Agreement have been satisfied, primarily completion of
satisfactory due diligence investigations by both parties and the completion
of the audits of the financial statements of the Caspian Companies.
Completion of the share exchange would represent a significant addition to
the business plan of CRSI Group.

ITEM 3.  CONTROLS AND PROCEDURES

     Evaluation of Disclosure Controls and Procedures.  Jeremy Feakins,
our Chief Executive Officer and Chief Financial Officer, carried out an
evaluation of the effectiveness of Abcor's  disclosure controls and
procedures as of September 30, 2005.  Pursuant to Rule13a-15(e) promulgated
by the Securities and Exchange Commission pursuant to the Securities
Exchange Act of 1934, "disclosure controls and procedures" means controls
and other procedures that are designed to insure that information required
to be disclosed by Abcor in the reports that it files with the Securities
and Exchange Commission is recorded, processed, summarized and reported
within the time limits specified in the Commission's rules.  "Disclosure
controls and procedures" include, without limitation, controls and
procedures designed to insure that information Abcor is required to
disclose in the reports it files with the Commission is accumulated and
communicated to our Chief Executive Officer and Chief Financial Officer as
appropriate to allow timely decisions regarding required disclosure.  Based
on his evaluation, Mr. Feakins concluded that Abcor's system of disclosure
controls and procedures was effective as of September 30, 2005 for the
purposes described in this paragraph.

                                   -19-
<PAGE>

     Changes in Internal Controls.  There was no change in internal
controls over financial reporting (as defined in Rule 13a-15(f) promulgated
under the Securities Exchange Act or 1934) identified in connection with
the evaluation described in the preceding paragraph that occurred during
CRSI Group's third fiscal quarter that has materially affected or is
reasonably likely to materially affect CRSI Group's internal control over
financial reporting.


PART II   -   OTHER INFORMATION

Item 2.  Changes in Securities and Small Business Issuer Purchase of Equity
         Securities

     (c) Unregistered sales of equity securities

     None.

     (e) Purchases of equity securities

     The Company did not repurchase any of its equity securities that were
registered under Section 12 of the Securities Exchange Act during the 3rd
quarter of 2005.

Item 6.	Exhibits

     31  Rule 13a-14(a) Certification
     32  Rule 13a-14(b) Certification


                                  SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this Report to be signed on its
 behalf by the undersigned thereunto duly authorized.

                                        CRSI GROUP, INC.


Date: March 30, 2006			By: /s/ Jeremy Feakins
                                        ----------------------------------
                                        Jeremy Feakins, Chief Executive
                                         Officer, Chief Financial Officer,
                                         Chief Accounting Officer